Rare malignant formation of the dorsum of the foot (clinical case)
Year: 2022, volume 18 Issue: №1 Pages: 34-37
Heading: Traumatology and Orthopedics Article type: Case report
Authors: Myskin S.A., Shalin V.V., Mironov V.S., Mironov A.V., Belousov D.G., Bekker Yu.N.
Organization: Clinical Hospital №6 n. a. G.A. Zakharyin, Penza, National Research Ogarev Mordovia State University, Institute of Medicine
Heading: Traumatology and Orthopedics Article type: Case report
Authors: Myskin S.A., Shalin V.V., Mironov V.S., Mironov A.V., Belousov D.G., Bekker Yu.N.
Organization: Clinical Hospital №6 n. a. G.A. Zakharyin, Penza, National Research Ogarev Mordovia State University, Institute of Medicine
Summary:
Objective: to describe a malignant synovial sarcoma of rare localization. Synovial sarcoma is a soft tissue tumor originating from connective tissue, mainly from the synovial membrane of the joints. However, there are also rare localizations. This clinical case demonstrates the need for a more detailed diagnosis of neoplasms and demonstrates the need for early initiation of surgical and conservative treatment.
Keywords: synovial sarcoma, tumor of foot
Bibliography:
1. Suurmeijer A, de Bruijn D, Geurts van Kessel A, et al. Synovial sarcoma. In: Fletcher CD, Bridge JA, Hogendoorn P, Mertens F, eds. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC, 2013; 213-5.
2. Corey RM, Swett K, Ward WG. Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report. Cancer Med 2014; 3 (5): 1404-1415. DOI: 10.1002/cam4.288.
3. Vlenterie M, Ho VK, Kaal SE, et al. Age as an independent prognostic factor for survival of localized synovial sarcoma
patients. BrJ Cancer 2015; 113(11): 1602-6. DOI: 10.1038/bjc. 2015.375.
4. Wang S, Song R, Sun T, et al. Survival changes in patients with synovial sarcoma, 1983-2012. J Cancer 2017; 8 (10): 1759-68. DOI: 10.7150/jca. 17349.
5. Vlenterie M, Litiere S, Rizzo E, et al. Outcome of chemotherapy in advanced synovial sarcoma patients: review of 15 clinical trials from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity. Eur J Cancer 2016; (58): 62-72. DOI: 10.1016/j.ejca.2016.02.002.
6. Saponara M, Stacchiotti S, Casali PG, Gronchi A. (Neo) adjuvant treatment in localized soft tissue sarcoma: the unsolved affair. Eur J Cancer 2017; (70): 1-11. DOI: 10.1016/j.ejca. 2016.09.030.
7. Ferrari A, De Salvo GL, Brennan B, et al. Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005). Ann Oncol 2015; 26 (3): 567-72. DOI: 10.1093/an-nonc/mdu562.
8. Fletcher CDM, Unni KK, Mertens F, eds. Pathology and genetics of tumours of soft tissue and bone. Lyon, France: IARC Press, 2002; 427 p.
9. Artico R, Bison E, Brotto M. Monophasic synovial sarcoma of hypopharynx: case report and review of the literature. Acta Otorhinolaryngol Ital 2004; (24): 33-6.
10. Barkan GA, El-Naggar AK. Primary synovial sarcoma of the parotid gland. Ann Diagn Pathol 2004; 8 (4): 233-6.
11. Gronchi A, Maki RG, Jones RL. Treatment of soft tissue sarcoma: a focus on earlier stages. Future Oncol 2017; 13 (1 s): 13-21. DOI: 10.2217/fon-2016-0499.
| Attachment | Size |
|---|---|
| 2022_01_034-037.pdf | 898.98 KB |
Русский
English